Abstract
HIV establishes a reservoir in latently infected T cells, and this reservoir has long hampered curative approaches. A recent study by Descours et al. identifies CD32a as a marker of latently infected T cells, potentially opening the way to the development of strategies that directly target this critical HIV reservoir.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, N.I.H., Extramural
-
Comment
MeSH terms
-
Biomarkers / metabolism
-
CD4-Positive T-Lymphocytes / immunology
-
CD4-Positive T-Lymphocytes / virology*
-
Gene Expression
-
HIV Infections / genetics
-
HIV Infections / immunology
-
HIV Infections / therapy
-
HIV Infections / virology*
-
HIV-1 / pathogenicity
-
HIV-1 / physiology*
-
Humans
-
Molecular Targeted Therapy
-
RNA, Viral / genetics
-
RNA, Viral / immunology
-
Receptors, IgG / genetics*
-
Receptors, IgG / immunology
-
Virus Activation
-
Virus Latency*
Substances
-
Biomarkers
-
Fc gamma receptor IIA
-
RNA, Viral
-
Receptors, IgG